J&J Units Sue Nova Over Alleged Patent Infringement
By Olivia Thomson · October 22, 2026, 6:11 AM EDT
Two Johnson & Johnson subsidiaries have sued Nova Pharmaceuticals Australasia over two treatments that allegedly infringe a patent of one of the units, Actelion, claiming the rival threatened to market and...
To view the full article, register now.
Try Law360 Australia FREE for fourteen days
Already a subscriber? Click here to login